# Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?

> **NCT03945708** · NA · COMPLETED · sponsor: **Emma Hansson** · enrollment: 20 (actual)

## Conditions studied

- Infective Endocarditis

## Interventions

- **DEVICE:** CytoSorb

## Key facts

- **NCT ID:** NCT03945708
- **Lead sponsor:** Emma Hansson
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-15
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03945708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03945708, "Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03945708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*